FDA Inspection 996682 — Cedar Pharmaceuticals LLC
The FDA completed an inspection of Cedar Pharmaceuticals LLC on Nov 15, 2016 in Shreveport, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 15, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shreveport, LA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)